Clinical Trial Update: Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver Transplant [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated sorafenib tosylate in adults with hepatocellular carcinoma or other primary liver cancers after liver transplantation; the trial has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Nexavar (Sorafenib)

Snippet

Sponsor: University of Washington | Conditions: Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer | Phase 1 | Status: COMPLETED